Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Germ-line heterozygous mutations in the hematopoietic transcription factor AML1 (RUNX1) have been identified in patients with familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML), which is characterized by thrombocytopenia, abnormal platelet function, and propensity to myeloid malignancies. We identified a novel mutation in the AML1 gene in an FPD/AML pedigree characterized by a single nucleotide deletion that generates a frameshift and premature chain termination (Pro218fs-Ter225). Both wild-type and mutant transcripts were expressed in affected individuals by allele-specific reverse transcriptase-polymerase chain reaction (RT-PCR). Thrombopoietin (TPO) binds to the Mpl receptor and is the major regulator of megakaryopoiesis. To explore the mechanisms underlying thrombocytopenia, we studied the TPO/Mpl pathway in this newly identified pedigree. TPO levels were mildly to moderately elevated. On flow cytometry and immunoblotting, Mpl receptor expression was decreased and TPO-induced signaling was impaired. While no mutations were identified in the MPL gene by sequence analysis, low MPL mRNA levels were found, suggesting decreased gene expression. Of particular interest, several AML1-binding motifs are present in the MPL promoter, suggesting MPL is an AML1 target. In conclusion, we identified a C-terminal AML1 mutation that leads to a decrease in Mpl receptor expression, providing a potential explanation for thrombocytopenia in this FPD/AML pedigree.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transcripts from these mutated RUNX1 genes can escape nonsense-mediated decay, resulting in expression of RUNX1 variants that lack the C-terminus.43”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [43]
Citations
Cites
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
BORN, G. V. R. (1962) · Nature · doi:10.1038/194927b0 · Cited by 4,294
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856 · cited 1×
“This transcription factor is essential for the establishment of definitive hematopoiesis, as demonstrated in AML1 -/- mice which show a complete absence of fetal liver hematopoiesis and die during embryonic development, precluding analysis of the effects of AML1 in later stages of blood cell development.(10) The role…”
MethodSong, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Nonsense-mediated decay approaches the clinic
Holbrook, J. A., Neu-Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004) · Nature Genetics · doi:10.1038/ng1403 · Cited by 596 · cited 1×
“Most transcripts harbouring premature termination codons are subjected to degradation by nonsense-mediated decay.(27) Nonsense mutations might therefore act in vivo predominantly via haploinsufficiency rather than in a dominant-negative manner.”
BackgroundIchikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., et al. (2004) · Nature Medicine · doi:10.1038/nm997 · Cited by 596
Alexander, W., Roberts, A., Nicola, N., Li, R., & Metcalf, D. (1996) · Blood · doi:10.1182/blood.v87.6.2162.bloodjournal8762162 · Cited by 577
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Broudy, V., Lin, N., & Kaushansky, K. (1995) · Blood · doi:10.1182/blood.v85.7.1719.bloodjournal8571719 · Cited by 390
Kuter, D., & Rosenberg, R. (1995) · Blood · doi:10.1182/blood.v85.10.2720.bloodjournal85102720 · Cited by 379 · cited 1×
“TPO levels in affected individuals Plasma TPO is cleared by binding to the Mpl receptor followed by internalization and degradation.(20) TPO levels were non-detectable in 12 out of 17 control subjects (detection limit of the assay 7.”
Background
Cited by
Role of RUNX1 in hematological malignancies
Sood, R., Kamikubo, Y., & Liu, P. (2017) · Blood · doi:10.1182/blood-2016-10-687830 · Cited by 494
Megakaryocyte development and platelet production
Deutsch, V. R., & Tomer, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06215.x · Cited by 311
“Chromosomal translocations in the RUNX1 gene is frequently associated with leukaemia, for example the t(8;21) in AML resulting in a dominant-negative RUNX1-ETO fusion protein.”
BackgroundInfluentialOwen, C. J., Toze, C. L., Koochin, A., Forrest, D. L., Smith, C. A., Stevens, J. M., Jackson, S. C., Poon, M.-C., Sinclair, G. D., Leber, B., et al. (2008) · Blood · doi:10.1182/blood-2008-05-156745 · Cited by 242
Cai, X., Gao, L., Teng, L., Ge, J., Oo, Z. M., Kumar, A. R., Gilliland, D. G., Mason, P. J., Tan, K., & Speck, N. A. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.002 · Cited by 235
“Runx1 directly regulates several cytokine receptors including MPL, the receptor for thrombopoietin (TPO), an important regulator of HSC function (Cai et al., 2011; Heller et al., 2005; Kimura et al., 1998; Solar et al., 1998).”
Recent advances in the understanding and management of MYH9‐related inherited thrombocytopenias
Balduini, C. L., Pecci, A., & Savoia, A. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08716.x · Cited by 232
“Oral contraceptives are effective in preventing menorrhagia, but they increase the risk of thrombosis, which should always be considered also in thrombocytopenic patients (McDunn et al, 1991; Goto et al, 1998; Heller et al, 2005).”
Background
Metadata
- Authors
- Heller, P. G., Glembotsky, A. C., Gandhi, M. J., Cummings, C. L., Pirola, C. J., Marta, R. F., Kornblihtt, L. I., Drachman, J. G., & Molinas, F. C.
- Affiliations
- University of Washington (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2005-06-15
- Volume
- 105
- Issue
- 12
- Pages
- 4664-4670
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2058237334
- Cited by
- 104
- References
- 35
- Citations by year
- 2025: 3 · 2024: 4 · 2022: 2 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 9 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 4 · 2012: 7
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- RUNX1, Mpl receptor, thrombopoietin signaling, thrombocytopenia, frameshift mutation, megakaryopoiesis, C-terminal mutations
- MeSH terms
- Adolescent, Adult, Alleles, Blood Platelet Disorders, Blood Platelets, DNA, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Exons, Family Health, Female, Flow Cytometry, Gene Expression Regulation, Heterozygote, Humans, Male, Middle Aged, Models, Genetic, Mutation, Pedigree, Phosphorylation, Promoter Regions, Genetic, Protein Binding, Proto-Oncogene Proteins, RNA, Messenger, Thrombocytopenia, Thrombopoietin, Transcription Factors, Tyrosine, Immunoblotting, Blotting, Western, Signal Transduction, Leukemia, Myeloid, Acute, Frameshift Mutation, DNA Primers, Germ-Line Mutation, Receptors, Cytokine, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Amino Acid Motifs, Core Binding Factor Alpha 2 Subunit, Receptors, Thrombopoietin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. https://app.cochat.ai/papers/10.1182/blood-2005-01-0050
- The paper
- Heller, P. G., Glembotsky, A. C., Gandhi, M. J., Cummings, C. L., Pirola, C. J., Marta, R. F., Kornblihtt, L. I., Drachman, J. G., & Molinas, F. C. (2005). Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood. https://doi.org/10.1182/blood-2005-01-0050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.